Sue-Hwa Lin

9PUBLICATIONS
28CO-AUTHORS
Solid tumoursPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 12, 2025
Activating RET Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer.

Rozita Bagheri-Yarmand, Gabriel M Pagnotti, Joseph L Kidd

|Nov 06, 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer.

Emanuela Gentile, Andrew W Hahn, Jian H Song

|Jul 08, 2022
Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.

Guoyu Yu, Paul G Corn, Pengfei Shen

|Nov 30, 2021
Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition.

Yu-Chen Lee, Song-Chang Lin, Guoyu Yu

|Sep 02, 2021
P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis.

Ming Zhu, Ruiqing Peng, Xin Liang

|Jun 15, 2021
Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone.

Tianhong Pan, Song-Chang Lin, Yu-Chen Lee

Pageof 2

Frequent Collaborators

3 joint publications

Sue-Hwa Lin

2 joint publications

Guocan Wang

2 joint publications

Theocharis Panaretakis

2 joint publications

Christopher J Logothetis